A Phase 3b/4 Randomized Double Blind Placebo Controlled Study Of Methotrexate (MTX) Withdrawal In Subjects With Rheumatoid Arthritis (RA) Treated With Tofacitinib 11mg Modified Release (MR) Formulation
Phase of Trial: Phase III/IV
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Tofacitinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 10 Jun 2017 Biomarkers information updated
- 30 Sep 2016 Planned End Date changed from 1 Feb 2019 to 1 Mar 2019.
- 30 Sep 2016 Planned primary completion date changed from 1 Feb 2019 to 1 Mar 2019.